Nov 1, 2017 8:30 am EDT EyeGate Appoints Mike Garanzini as Chief Commercial Officer to Develop and Implement Global Launch Strategy
Sep 11, 2017 6:30 am EDT EyeGate Launches Social Media Pages to Enhance Investor and Trade Relationships
Sep 5, 2017 6:30 am EDT EyeGate Pharma to Present at the 19th Annual Rodman and Renshaw Global Investment Conference
Aug 7, 2017 7:30 am EDT EyeGate Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
Aug 1, 2017 7:30 am EDT EyeGate Pharma Enrolls First Patient in Phase 2b Clinical Study of EGP-437 for Cataract Surgery
May 22, 2017 7:30 am EDT EyeGate Receives Milestone Payment from Valeant Pharmaceuticals for EGP-437 for post-operative ocular inflammation and pain in ocular surgery patients
May 8, 2017 8:30 am EDT EyeGate Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update